UISEE TECH (01511) and TOPNC (07688) have concluded their public offerings, while TENNOR THERAP-B (06872) remains in the subscription period. As of May 15, data from brokers including Futu Securities and Tiger Brokers shows that margin financing for UISEE TECH reached HKD 225.872 billion, representing an oversubscription of over 5,179.55 times. Financing for TOPNC amounted to HKD 499.141 billion, with an oversubscription exceeding 2,894.08 times. For TENNOR THERAP-B, margin financing stood at HKD 5.067 billion, indicating an oversubscription of more than 79.83 times.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments